top of page
shutterstock_691541095.jpg

Partners

Incubate.jpg

Incubate 2 great

Today, brands are facing major challenges. The speed and complexity of business is constantly increasing.

We want to provide orientation by understanding your brand and your business, developing an effective strategy together with your employees and delivering results.

At the same time, we are committed to the future of your brand by bringing your big ideas back home and connecting them to your existing business model.

 

Via this platform, we create a top brand and arise awareness of our client companies from the beginning on.

CLUE.jpg

Clue Solutions

The right partner in Switzerland and Southeast Asia.

Since 2012 Clue is offering services and support in marketing, communications, and consulting, with offices in Zurich and Kuala Lumpur – and a geographical focus on Southeast Asia. Markus Helbling is Founder and Managing Director of Clue and has years of proven track record and experience in the areas of general management, project management and business development.

Additionally, Clue offers Swiss companies comprehensive services, including implementation, execution, and operational management and support for their projects and products in Southeast Asia.

NBS.jpg

Other Partners

We work with a number of international venture capitalists who are specializing in biopharma investments – in various stages, from early up to later stages. As they are linked to trusts, we have the opportunity to create a dedicated institutional investor base from the very beginning.

As a Fund Manager and Analyst in the pharma industry with over 20 years of experience, I managed to build long-lasting relationships to the C-level as well as to many top managers of the big players in the pharma industry and the respective companies. It allows me to create strategic collaborations, value creation and/or to get corporate venture capitalists on board as investors.

 

I have always taken care of my roots and my network in the academic community. Professors at universities around the world can support us in doing evaluations of the technologies and projects of my clients’ companies. This procedure can be compared to an independent review process of scientific papers and is therefore very helpful for the validation of technologies and projects.

“I have got to know and appreciate Dr. Michael Nawrath during his PhD thesis in biochemistry. Through his extensive training as a doctor and scientist as well as his many years of experience as a fund manager and pharmaceutical analyst, Dr. Michael Nawrath has built up an enormous basic knowledge of the entire biopharmaceutical sector. This enables him to assess the potential of startups in the health care sector quickly and comprehensively.”

Dr. Jovan Pavlovic, Doctor of Science
Co-lead of the Swiss Covid Reference Laboratory of the University of Zurich, previously Group Leader, Medical Virology, University of Zurich

bottom of page